Daily physical activity patterns in children and adolescents with inflammatory bowel disease

Jérémy Vanhelst1,2, Laurent Béghin3,4, Dominique Turck3,5

  • 1Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, 59000, Lille, France. jeremy.vanhelst@chru-lille.fr.

Pediatric Research
|January 20, 2021
PubMed

Insights

Children and adolescents with inflammatory bowel disease (IBD) show similar physical activity (PA) levels to healthy peers, though males with IBD engage in less moderate-to-vigorous PA. Most IBD patients do not meet daily PA recommendations.

Area of Science:

  • Pediatric gastroenterology
  • Clinical research
  • Public health

Background:

  • Limited data exists on physical activity (PA) patterns in pediatric patients diagnosed with inflammatory bowel disease (IBD).
  • Assessing PA in this population is crucial for understanding overall health and disease management.
  • Methodological challenges in previous PA assessments necessitate objective measurement approaches.

Purpose of the Study:

  • To evaluate and compare physical activity patterns in children and adolescents with IBD against healthy controls.
  • To identify potential differences in PA levels and adherence to health recommendations between IBD patients and their healthy peers.
  • To investigate PA patterns across different IBD subtypes and disease activity levels.

Main Methods:

  • A cohort of 60 pediatric patients with IBD (Crohn's disease, ulcerative colitis, IBD-unclassified) in remission or with mild disease was studied.
  • Participants were compared with 60 age- and sex-matched healthy controls.
  • Objective PA quantification was performed using triaxial accelerometers worn for four consecutive days.

Main Results:

  • No significant overall difference in daily PA patterns was observed between IBD patients and healthy controls.
  • 31.7% of IBD patients and 38.3% of controls met the recommended 60 minutes of daily moderate-to-vigorous physical activity (MVPA).
  • Male patients with IBD showed significantly less MVPA (16.2 min/day) than controls, while females did not differ; sedentary patterns were similar.

Conclusions:

  • Children and adolescents with inactive or mild IBD exhibit comparable PA patterns to healthy individuals, with the exception of reduced MVPA in males.
  • A majority of pediatric IBD patients do not achieve the recommended daily MVPA for optimal health benefits.
  • These findings highlight the need for targeted PA interventions, particularly for male patients with IBD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
504
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
621
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
572
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
635
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
301
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
302